Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78-week randomized, double-blind, placebo-controlled trial (Q37279276)
Jump to navigation
Jump to search
scientific article published on 04 June 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78-week randomized, double-blind, placebo-controlled trial |
scientific article published on 04 June 2015 |
Statements
1 reference
Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78-week randomized, double-blind, placebo-controlled trial (English)
1 reference
J Rosenstock
1 reference
A Jelaska
1 reference
C Zeller
1 reference
G Kim
1 reference
U C Broedl
1 reference
H J Woerle
1 reference
EMPA-REG BASALTM trial investigators
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference